Earnings call transcript: Erlikon Q2 2025 sees stable orders amid market headwinds

Erlikon's Q2 2025 results revealed a 3% decline in group sales (constant FX) and a reduced operational EBITDA margin of 16.7%, reflecting significant market headwinds and geopolitical uncertainties, which also led to €46 million in R&D and business impairments. Despite these pressures, orders remained stable with a book-to-bill ratio above one. The company reaffirmed its full-year margin guidance of 17-17.5%, emphasizing ongoing cost-saving initiatives and the planned divestment of Baumark to deleverage and reduce pension liabilities, aiming for long-term profitability amidst challenging market conditions.

Analysis

Erlikon's second-quarter 2025 results present a narrative of operational resilience against significant macroeconomic pressure. Group sales declined by 3% at constant FX to CHF 786 million, and the operational EBITDA margin contracted to 16.7%, reflecting headwinds across 80% of its end markets, particularly in automotive and general industries. Despite this, order intake remained stable at CHF 826 million, supporting a book-to-bill ratio above 1, which indicates a solid demand pipeline and potential market share gains driven by the company's strong technology position. Management is actively navigating the downturn through strategic restructuring, evidenced by a EUR 46 million impairment on select R&D projects and business units as part of its transition to a 'pure play' entity. The planned divestment of the Baumark division is a critical near-term catalyst, with proceeds earmarked for deleveraging to a target ratio below 2x and a significant reduction in pension liabilities. The full-year guidance for an operational EBITDA margin between 17% and 17.5% suggests an anticipated improvement in the second half, contingent on the benefits from cost-saving measures and no further escalation in geopolitical or trade tensions.

Key Decisions for Investors

• Investors should assess the current valuation by weighing the near-term margin pressure from widespread market headwinds against the long-term value creation potential from the 'pure play' transformation, which includes significant deleveraging and pension liability reduction following the Baumark divestiture.
• The successful closing of the Baumark sale in Q4 2025 is a critical catalyst to monitor, with a focus on the subsequent debt reduction to below a 2x leverage ratio and any potential for a special dividend distribution from the proceeds.
• Given the company's high sensitivity to the industrial cycle, it is prudent to track key macroeconomic indicators such as Euro Area PMIs and global trade tariff developments, as management linked the lower end of its 17% margin guidance to further geopolitical escalations.
• Consider the resilient order book, with a book-to-bill ratio consistently above 1, as evidence of the company's strong technological positioning, which could enable an accelerated recovery and margin expansion once its key end markets stabilize or improve.